戻る Agenda
Strategic Priorities of the International Coalition of Medicines Regulatory Authorities in an Increasingly Globalized Industry
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
The International Coalition of Medicines Regulatory Authorities (ICMRA) will explore its strategic priorities in the context of a globalized world. To overcome these challenges ICMRA can champion greater harmonisation and convergence. The session will be delivered by members of ICMRA and conclude with a panel discussion of questions raised by the audience.
Learning Objective : Describe strategic priorities of ICMRA in the context of the globalized world.
Speaker(s)
Overview of ICMRA and Strategic Priorities: Including Vigilance, Track, and Trace
Guido Rasi, MD
Tor Vergata University of Rome, Italy
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology
The 'Innovation' Priority Project
Lorraine Nolan, PHD
Health Products Regulatory Authority , Ireland
Chief Executive
Current Topics of Interest to ICMRA Members Including Biosimilars and AMR
John Skerritt, PHD
University of Melbourne, Australia
Enterprise Professor, Health Research Impact
Panelist
Yasuhiro Fujiwara, MD, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
IFPMA View
David B. Jefferys, MD, FRCPC
EISA EUROPE LTD, United Kingdom
Senior Vice President